The Grb2 Binding Site Is Required for the Induction of Chronic Myeloid Leukemia-Like Disease in Mice by the BCR/Abl Tyrosine Kinase

Blood- United States

doi 10.1182/blood.v96.2.664.014k52_664_670

Full Text

Abstract

Available in

Categories

Date

July 15, 2000

Authors

Ryan P. Million

Richard A. Van Etten

Publisher

American Society of Hematology

Related search

The Grb2 Binding Site Is Required for the Induction of Chronic Myeloid Leukemia-Like Disease in Mice by the BCR/Abl Tyrosine Kinase

English

Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors

Cancer Medicine

Cancer Research

Nuclear Medicine

English

Differential Genomics and Transcriptomics Between Tyrosine Kinase Inhibitor-Sensitive and -Resistant BCR-ABL-dependent Chronic Myeloid Leukemia

English

BCR-ABL Tyrosine Kinase

Science-Business eXchange

English

Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-Like Myeloproliferative Disease in a Murine Model

English

Current Status of ABL Tyrosine Kinase Inhibitors Stop Studies for Chronic Myeloid Leukemia

Stem Cell Investigation

English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

English

Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model

English

IPO-trimethylation of Histone H3-Lysine9associated With P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia

British Journal of Haematology

English